Your browser doesn't support javascript.
loading
HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.
Griggio, Valentina; Vitale, Candida; Todaro, Maria; Riganti, Chiara; Kopecka, Joanna; Salvetti, Chiara; Bomben, Riccardo; Bo, Michele Dal; Magliulo, Daniela; Rossi, Davide; Pozzato, Gabriele; Bonello, Lisa; Marchetti, Monia; Omedè, Paola; Kodipad, Ahad Ahmed; Laurenti, Luca; Del Poeta, Giovanni; Mauro, Francesca Romana; Bernardi, Rosa; Zenz, Thorsten; Gattei, Valter; Gaidano, Gianluca; Foà, Robin; Massaia, Massimo; Boccadoro, Mario; Coscia, Marta.
Afiliación
  • Griggio V; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy.
  • Vitale C; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Todaro M; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy.
  • Riganti C; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Kopecka J; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy.
  • Salvetti C; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Bomben R; Department of Oncology, University of Turin, Turin, Italy.
  • Bo MD; Department of Oncology, University of Turin, Turin, Italy.
  • Magliulo D; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy.
  • Rossi D; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Pozzato G; Clinical and Experimental Onco-Hematology Unit, CRO Aviano National Cancer Institute, Aviano, Italy.
  • Bonello L; Clinical and Experimental Onco-Hematology Unit, CRO Aviano National Cancer Institute, Aviano, Italy.
  • Marchetti M; Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Omedè P; Department of Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.
  • Kodipad AA; Department of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Trieste, Italy.
  • Laurenti L; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Del Poeta G; Hematology Day Service, Oncology SOC, Hospital Cardinal Massaia, Asti, Italy.
  • Mauro FR; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy.
  • Bernardi R; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Zenz T; Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.
  • Gattei V; Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
  • Gaidano G; Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Rome, Italy.
  • Foà R; Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Massaia M; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
  • Boccadoro M; Clinical and Experimental Onco-Hematology Unit, CRO Aviano National Cancer Institute, Aviano, Italy.
  • Coscia M; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
Haematologica ; 105(4): 1042-1054, 2020 04.
Article en En | MEDLINE | ID: mdl-31289209

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Animals / Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Animals / Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article País de afiliación: Italia